849059-79-6Relevant academic research and scientific papers
N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: Design, synthesis, SAR studies, and in vivo antitumor activity
Wang, Haishan,Yu, Niefang,Song, Hongyan,Chen, Dizhong,Zou, Yong,Deng, Weiping,Lye, Pek Ling,Chang, Joyce,Ng, Melvin,Sun, Eric T.,Sangthongpitag, Kanda,Wang, Xukun,Wu, Xiaofeng,Khng, Hwee Hoon,Fang, Lijuan,Goh, Siok Kun,Ong, Wai Chung,Bonday, Zahid,Stuenkel, Walter,Poulsen, Anders,Entzeroth, Michael
scheme or table, p. 1403 - 1408 (2009/10/15)
A series of N-hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides were designed and synthesized as novel HDAC inhibitors. General SAR has been established for the substituents at positions 1 and 2, as well as the importance of the ethylene group an
COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT
-
Page/Page column 76, (2008/12/08)
The present invention relates to a pharmaceutical composition for the treatment of cancer as well as methods of treatment of cancer that are based on the finding that certain benzimidazole based anti-cancer agents can be used in combination with a second
HETEROCYCLIC COMPOUNDS
-
Page/Page column 85-86, (2008/06/13)
The present invention relates to compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to heterocyclic compounds and methods for their preparation. These compounds may be useful as medicaments for the trea
